Rheumatoid arthritis is a chronic autoimmune disease that primarily affects the small joints and it’s the focus of this ...

Like many autoimmune diseases, rheumatoid arthritis (RA) can be challenging to manage. However, research has shown promise ...

Samsung Bioepis Co., a biosimilar medicine developer under Samsung Group, said Tuesday it has launched its biosimilar product ...

Biocon Biologics launches YESINTEK (ustekinumab-kfce), a biosimilar for Crohn's disease, ulcerative colitis, plaque psoriasis ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...

As a former consultant rheumatologist, I understand the enormous burden of arthritis. Here are the foods to eat to ease your ...

Vitiligo is a condition characterized by a loss of pigment (melanin), which results in the most common symptom: white or ...

Celltrion announced on the 24th that it has received product approval from the European Commission (EC) for ACTEMRA ...

Frequent sauna users often experience a wide range of mental benefits.

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

Biocon share price rose by 2.5% after its arm launched Yesintek, a biosimilar for autoimmune disorders in the US. Approved ...

Kiniksa’s actions leave it focused on a cardiovascular disease pipeline led by the IL-1 antagonist KPL-387. The program is ...